Levobupivacaine Hydrochloride Generics Suppliers & Bulk Manufacturers
Available Forms: Sterile solution for injection
Available Strengths: 0.25% (2.5 mg/mL), 0.5% (5 mg/mL), 0.75% (7.5 mg/mL)
Reference Brands: Chirocaine (US & EU)
Category:
Anaesthetics
Levobupivacaine Hydrochloride is a long-acting local anesthetic used in regional anesthesia, available in 0.25%, 0.5%, and 0.75% strengths. Approved in the US and EU under Chirocaine® and generics.
Levobupivacaine Hydrochloride Generics is available in Sterile solution for injection
and strengths such as 0.25% (2.5 mg/mL), 0.5% (5 mg/mL), 0.75% (7.5 mg/mL).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levobupivacaine Hydrochloride Generics is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levobupivacaine Hydrochloride Generics can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Levobupivacaine Hydrochloride is a long-acting local anesthetic used in regional anesthesia, including epidural, spinal, and peripheral nerve blocks. As the S-enantiomer of bupivacaine, it provides effective sensory and motor block with a lower risk of cardiotoxicity and CNS side effects, making it ideal for surgical, obstetric, and postoperative pain management. Available as a sterile injectable solution in 0.25%, 0.5%, and 0.75% concentrations, it is approved in the US (FDA) and EU (EMA) under brands such as Chirocaine® and various generics. Ideal for pharma B2B partners, hospital tenders, and anesthesia portfolios in regulated markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing